Literature DB >> 2872388

Presynaptic beta-adrenoceptors.

Y Misu, T Kubo.   

Abstract

The existence of facilitatory presynaptic beta-adrenoceptors has been shown in approximately 30 tissues of 6 different species including human. A positive feed back loop for further release of the transmitter appears to be activated by an endogenous agonist, epinephrine, taken up and released as a cotransmitter with norepinephrine rather than norepinephrine itself released from peripheral noradrenergic nerve terminals. Presynaptic beta-adrenoceptors are mainly of a beta 2-subtype. Some beta 1-subtype receptors are also suggested. There coexist presynaptic beta 1- and beta 2-adrenoceptors in cat and rat hypothalamus. Higher sensitivity of peripheral presynaptic beta-adrenoceptors to isoproterenol may be implicated in the early development of hypertension in SHR. Epinephrine taken up and released initiates the development of hypertension in rats via activation of these receptors. Increased activation of these receptors by epinephrine may play a role in the development of essential hypertension. The antihypertensive action of beta-antagonists may be in part due to blockade of these facilitatory presynaptic beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872388     DOI: 10.1002/med.2610060204

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  25 in total

1.  Effect of isoprenaline on noradrenaline release from sympathetic neurones in rabbit isolated pulmonary artery.

Authors:  O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.

Authors:  E B Erdtsieck-Ernste; M G Feenstra; M H Botterblom; J De Barrios; G J Boer
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors.

Authors:  K D Murugaiah; J M O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

4.  Probable involvement of vascular angiotensin II formation in the beta 2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat.

Authors:  E Schlicker; K Erkens; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

5.  Adrenaline-induced enhancement of the blood pressure response to sympathetic nerve stimulation in adrenal demedullated pithed rats.

Authors:  V I Tarizzo; C Dahlöf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

6.  Beta-adrenoceptor-mediated facilitation of endogenous noradrenaline release from rat isolated trachea.

Authors:  G Brunn; I Wessler; G P Anderson; J Maclagan; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

7.  Evidence for tonic activation of prejunctional beta-adrenoceptors in guinea-pig pulmonary arteries by adrenaline derived from the adrenal medulla.

Authors:  Y Misu; M Kuwahara; H Amano; T Kubo
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

8.  Pre- and postganglionic stimulation-induced noradrenaline overflow is markedly facilitated by a prejunctional beta 2-adrenoceptor-mediated control mechanism in the pithed rat.

Authors:  V I Tarizzo; R P Coppes; C Dahlöf; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

9.  Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney.

Authors:  P P Lakhlani; F Amenta; P Napoleone; L Felici; D C Eikenburg
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.

Authors:  S Guimarães; A Albino-Teixeira; M Q Paiva
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.